Revolution Medicines, Inc. (RVMD)
USD 42.97
(-4.85%)
USD 42.97
(-4.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 11.58 Million | 35.38 Million | 29.39 Million | 42.98 Million | 50.04 Million | 20.16 Million |
| Cost of Revenue | 411.24 Million | 9.65 Million | 7.33 Million | 132.25 Million | 91.75 Million | 1.76 Million |
| Gross Profit | -399.66 Million | 25.72 Million | 22.05 Million | -89.26 Million | -41.71 Million | 18.4 Million |
| Operating Expenses | 498.76 Million | 293.65 Million | 217.39 Million | 153.68 Million | 104.16 Million | 60.49 Million |
| Selling, General and Administrative Expenses | 75.62 Million | 40.58 Million | 30.45 Million | 21.42 Million | 12.4 Million | 9.41 Million |
| Research and Development Expenses | 423.14 Million | 253.07 Million | 186.94 Million | 132.25 Million | 91.75 Million | 51.08 Million |
| Other Expenses | - | - | - | - | - | -2.12 Million |
| Cost and Expenses | 498.76 Million | 293.65 Million | 217.39 Million | 153.68 Million | 104.16 Million | 60.49 Million |
| Operating Income | -487.18 Million | -258.27 Million | -188 Million | -110.69 Million | -54.12 Million | -40.32 Million |
| Interest Expense | 303 Thousand | - | 12 Thousand | 71 Thousand | 106 Thousand | 116 Thousand |
| Income Tax Expense | -3.52 Million | -420 Thousand | -7.32 Million | -371 Thousand | -4.37 Million | -1.34 Million |
| Earnings before Tax | -439.89 Million | -249.12 Million | -187.09 Million | -108.53 Million | -52.03 Million | -41.78 Million |
| Net Income | -436.36 Million | -248.7 Million | -179.77 Million | -108.15 Million | -47.66 Million | -41.78 Million |
| Earnings Per Share Basic | -3.86 | -3.08 | -2.47 | -1.62 | -0.81 | -1.15 |
| Earnings Per Share Diluted | -3.86 | -3.08 | -2.47 | -1.62 | -0.81 | -1.15 |
| Weighted Average Shares Outstanding | 113.14 Million | 80.62 Million | 72.8 Million | 66.59 Million | 59 Million | 36.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 113.14 Million | 80.62 Million | 72.8 Million | 66.59 Million | 59 Million | 36.47 Million |
| Gross Margin | -34.51 | 0.73 | 0.75 | -2.08 | -0.83 | 0.91 |
| EBIT Margin | -37.18 | -7.04 | -6.37 | -2.52 | -0.97 | -1.98 |
| Profit Margin | -37.68 | -7.03 | -6.12 | -2.52 | -0.95 | -2.07 |
| EBITDA | -430.58 Million | -239.46 Million | -179.74 Million | -101.91 Million | -48.58 Million | -39.9 Million |
| Earnings Before Tax Margin | -42.07 | -7.30 | -6.40 | -2.58 | -1.08 | -2.00 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 11.58 Million | 742 Thousand | - | 3.82 Million |
| Cost of Revenue | 12.77 Million | 118.02 Million | 9.3 Million | 2.85 Million | 2.14 Million | 1.77 Million |
| Gross Profit | -12.77 Million | -118.02 Million | 2.27 Million | -2.11 Million | -2.14 Million | 2.05 Million |
| Operating Expenses | 143.86 Million | 22.83 Million | 489.45 Million | 177.86 Million | 123.24 Million | 112.62 Million |
| Selling, General and Administrative Expenses | 21.71 Million | 22.83 Million | - | 31 Million | 15.51 Million | 14.64 Million |
| Research and Development Expenses | 134.93 Million | 118.02 Million | - | 146.86 Million | 107.73 Million | 97.98 Million |
| Other Expenses | -12.77 Million | -118.02 Million | 115 Thousand | - | - | - |
| Cost and Expenses | 156.64 Million | 140.85 Million | 498.76 Million | 180.72 Million | 123.24 Million | 112.62 Million |
| Operating Income | -156.64 Million | -140.85 Million | -487.18 Million | -179.98 Million | -123.24 Million | -108.79 Million |
| Interest Expense | - | - | 303 Thousand | 9.28 Million | - | - |
| Income Tax Expense | - | - | -3.52 Million | 343 Thousand | 3.86 Million | -1.77 Million |
| Earnings before Tax | -133.23 Million | -116 Million | -439.89 Million | -161.19 Million | -112.3 Million | -98.29 Million |
| Net Income | -133.23 Million | -116 Million | -436.36 Million | -161.53 Million | -108.43 Million | -98.29 Million |
| Earnings Per Share Basic | -0.81 | -0.70 | - | -1.14 | -0.99 | -0.92 |
| Earnings Per Share Diluted | -0.81 | -0.70 | - | -1.14 | -0.99 | -0.92 |
| Weighted Average Shares Outstanding | 165.14 Million | 164.72 Million | 113.14 Million | 141.18 Million | 109.23 Million | 106.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 165.14 Million | 164.72 Million | 113.14 Million | 141.18 Million | 109.23 Million | 106.88 Million |
| Gross Margin | - | - | 0.20 | -2.85 | - | 0.54 |
| EBIT Margin | - | - | - | -238.71 | - | -28.45 |
| Profit Margin | - | - | -37.68 | -217.70 | - | -25.71 |
| EBITDA | -154.93 Million | -139.35 Million | - | -177.12 Million | -123.24 Million | -108.79 Million |
| Earnings Before Tax Margin | - | - | -42.07 | -242.56 | - | -28.45 |
UMI
SER
ZENSARTECH
MSP
TINS
JCGI